Clinical Trial Results:
Estudio de extension abierto, de 48 semanas de duracion, para evaluar la administracion de elvucitabina en combinacion con agentes antirretrovirales de base en sujetos que hayan completado 14 dias de tratamiento en el protocolo ACH443-014A.
(An open-label, 48-week extension study of elvucitabine administered in combination with background antiretroviral agents in subjects who have completed 14 days of treatment in Protocol ACH443-014A.)
Summary
|
|
EudraCT number |
2006-006194-25 |
Trial protocol |
ES DE |
Global completion date |
28 Nov 2008
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
14 Feb 2019
|
First version publication date |
14 Feb 2019
|
Other versions |
|
Summary report(s) |
Synopsis ACH443-018 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.